MedPath

Compare the Efficacy and Outcome Between Fentanyl and Morphine as Analgo-sedation in Mechanically Ventilated Patients

Phase 4
Not yet recruiting
Conditions
Effect of Drug
Interventions
Registration Number
NCT06479655
Lead Sponsor
Universiti Sains Malaysia
Brief Summary

The primary aim of this clinical trial is to compare the effectiveness of fentanyl vs morphine as analgosedation in mechanically ventilated adult patients in the ICU. This study also aims to compare the outcomes of patients between the two groups.

The main questions it aims to answer are :

1. Does propofol and fentanyl infusion as analgo-sedation achieve targeted sedation score at 12 and 24 hours compared to propofol and morphine infusion in mechanically ventilated adult patients in the intensive care unit (ICU)?

2. Is there a difference between the proportion of patients requiring rescue sedation dose between the fentanyl and morphine groups?

Detailed Description

Researchers will randomize patients into 2 groups (Fentanyl and Morphine) and will start study drug accordingly for sedation in ICU.Proportion of patients from each group achieving targeted sedation score at 12 and 24 hours following initiation of the drug and proportion of patients from each group requiring rescue sedation dose will be recorded and analyzed.

Furthemore duration of mechanical ventilation, length of ICU stay and 14 days mortality rate will recorded and compared between this 2 groups of patients.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Age >18 years old
  • Patients who are expected by the ICU team to require invasive mechanical ventilation in ICU for at least more than 24 hours and for whom the ICU team decides to initiate continuous infusion of sedation
  • A patient who was ventilated and sedated not more than 12 hours before ICU admission.
Exclusion Criteria
  • Patients with chronic use of narcotics
  • Patients with chronic liver failure or end-stage renal failure
  • Patients with severe chronic neurocognitive dysfunction
  • Patients with drug overdose
  • Patients with a known allergy to either morphine or fentanyl
  • Patients who are receiving neuromuscular blockers
  • Patients who are pregnant
  • Patients who are diagnosed to have severe traumatic brain in

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FentanylFentanylIntravenous fentanyl infusion 0.5 - 1 mcg/kg/hr
MorphineMorphineIntraveous morphine infusion 0.05 - 0.1 mg/kg/hr
Primary Outcome Measures
NameTimeMethod
RASS score at 12 and 24 hours24 hours from study drug initiation

To determine the proportion of patients achieving the targeted sedation guided by RASS score at 12 and 24 hours in both fentanyl and morphine group.

Rescue sedation doses24 hours from study drug initiation

To determine the proportion of patients requiring rescue sedation doses between fentanyl and morphine group

Secondary Outcome Measures
NameTimeMethod
Duration of mechanical ventilation90 Days

To compare the duration of mechanical ventilation between the fentanyl and morphine groups

Length of ICU stay90 days

To compare the length of ICU stay between the fentanyl and morphine groups

14 days mortality rate14 days from randomization

To compare 14-day mortality rates between the fentanyl and morphine groups

Trial Locations

Locations (1)

Mohd Zulfakar Mazlan, MBBS

🇲🇾

Kota Bharu, Kelantan, Malaysia

© Copyright 2025. All Rights Reserved by MedPath